Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)

China flag China · Delayed Price · Currency is CNY
9.85
-0.02 (-0.20%)
Jan 23, 2026, 3:00 PM CST
17.68%
Market Cap8.16B
Revenue (ttm)751.12M
Net Income (ttm)184.84M
Shares Out828.30M
EPS (ttm)0.22
PE Ratio44.49
Forward PE37.17
Dividend0.10 (1.01%)
Ex-Dividend DateJul 17, 2025
Volume10,010,007
Average Volume9,036,292
Open9.89
Previous Close9.87
Day's Range9.82 - 9.96
52-Week Range6.94 - 12.51
Beta-0.21
RSI46.97
Earnings DateApr 29, 2026

About SHA:603229

Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional industries. The company was founded in 2010 and is b... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 1,219
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603229
Full Company Profile

Financial Performance

In 2024, SHA:603229's revenue was 795.29 million, a decrease of -2.63% compared to the previous year's 816.77 million. Earnings were 206.79 million, a decrease of -18.55%.

Financial Statements